Skip to main content
logo
Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
5.11
-0.25 (-4.66%)
At close: Jul 10, 2026, 4:00 PM EDT
5.06
-0.05 (-0.98%)
After-hours: Jul 10, 2026, 4:45 PM EDT

Immuneering Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
----0.322.08
Revenue Growth (YoY)
-----84.76%-10.02%
Cost of Revenue
----0.161.15
Gross Profit
----0.160.93
Selling, General & Admin
17.9817.316.0816.7615.618.27
Depreciation & Amortization Expenses
0.030.030.030.030.03-
Research & Development
41.2242.0547.9641.6236.2726.54
Total Operating Expenses
59.2359.3864.0758.4151.934.81
Operating Income
-59.23-59.38-64.07-58.41-51.74-33.89
Interest Income
3.963.042.593.611.010.17
Other Non-Operating Income (Expense)
0.830.310.441.330.22-0.13
Total Non-Operating Income (Expense)
4.793.353.034.941.230.04
Pretax Income
-54.44-56.02-61.04-53.47-50.51-33.84
Provision for Income Taxes
------0.31
Net Income
-54.44-56.02-61.04-53.47-50.51-33.54
Net Income to Common
-54.44-56.02-61.04-53.47-50.51-33.54
Shares Outstanding (Basic)
514430282614
Shares Outstanding (Diluted)
514430282614
Shares Change (YoY)
62.53%46.80%5.51%7.69%93.84%175.00%
EPS (Basic)
-1.17-1.27-2.04-1.88-1.91-2.46
EPS (Diluted)
-1.17-1.27-2.04-1.88-1.91-2.46
Free Cash Flow
-49.91-45.49-55.08-49.31-44.84-30.91
Free Cash Flow Per Share
-0.97-1.03-1.84-1.74-1.70-2.27
Gross Margin
----50.11%44.56%
Operating Margin
-----16325.80%-1629.17%
Profit Margin
-----15937.30%-1612.33%
FCF Margin
-----14148.40%-1486.17%
EBITDA
-58.88-59.02-63.69-58.06-51.47-33.84
EBITDA Margin
-----16238.30%-1626.98%
EBIT
-59.23-59.38-64.07-58.41-51.74-33.89
EBIT Margin
-----16325.80%-1629.17%
Effective Tax Rate
-0.00%0.00%0.00%0.00%0.91%
SEC Filings: 10-K · 10-Q